STOCK TITAN

[8-K] BALCHEM CORP Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Balchem Corporation furnished an update on its business by reporting earnings for the quarter ended September 30, 2025. The company issued a press release with the results, which is attached as Exhibit 99.1.

The disclosure was provided under Item 2.02 and is designated as “furnished,” meaning it is not deemed filed under Section 18 of the Exchange Act. Balchem’s common stock trades on Nasdaq under the symbol BCPC.

Balchem Corporation ha fornito un aggiornamento sull’andamento aziendale riportando gli utili del trimestre conclusosi il 30 settembre 2025. L’azienda ha emesso un comunicato stampa con i risultati, allegato come Exhibit 99.1.

La divulgazione è stata fornita ai sensi della Item 2.02 ed è designata come “furnished”, il che significa che non è considerata depositata ai sensi della Sezione 18 del Securities Exchange Act. Le azioni ordinarie di Balchem sono negoziate sul Nasdaq con simbolo BCPC.

Balchem Corporation presentó una actualización de su negocio al reportar las ganancias del trimestre terminado el 30 de septiembre de 2025. La compañía emitió un comunicado de prensa con los resultados, que se adjunta como Exhibit 99.1.

La divulgación se proporcionó bajo el Item 2.02 y se designa como “furnished”, lo que significa que no se considera presentada conforme a la Sección 18 de la Exchange Act. Las acciones comunes de Balchem cotizan en Nasdaq bajo el símbolo BCPC.

Balchem Corporation은 2025년 9월 30일 종료된 분기의 수익을 보고함으로써 자사 사업에 대한 업데이트를 제공합니다. 회사는 결과를 담은 보도자료를 발표했고, 이는 Exhibit 99.1로 첨부되어 있습니다.

공시는 Item 2.02에 따라 제공되었으며 "furnished"로 지정되어, Exchange Act 제18조에 따라 제출로 간주되지 않음을 의미합니다. Balchem의 보통주는 나스닥에서 심볼 BCPC로 거래됩니다.

Balchem Corporation a fourni une mise à jour de ses activités en déclarant les résultats du trimestre terminé le 30 septembre 2025. La société a publié un communiqué de presse avec les résultats, qui est joint en tant que Exhibit 99.1.

La divulgation a été fournie en vertu de Item 2.02 et est désignée comme « furnished », ce qui signifie qu’elle n’est pas réputée déposée en vertu de la Section 18 du Exchange Act. Les actions ordinaires de Balchem se négocient au Nasdaq sous le symbole BCPC.

Balchem Corporation hat ein Update zu seinem Geschäft vorgelegt, indem es die Ergebnisse für das Quartal zum 30. September 2025 gemeldet hat. Das Unternehmen veröffentlichte eine Pressemitteilung mit den Ergebnissen, die als Exhibit 99.1 beigefügt ist.

Die Offenlegung wurde gemäß Item 2.02 bereitgestellt und ist als „furnished“ gekennzeichnet, was bedeutet, dass sie gemäß Section 18 des Exchange Act nicht als eingereicht gilt. Balchems Stammaktien werden an der Nasdaq unter dem Symbol BCPC gehandelt.

Balchem Corporation قد قدمت تحديثًا لعملها بالإبلاغ عن أرباح الربع المنتهي في 30 سبتمبر 2025. أصدرت الشركة بيانًا صحفيًا بالنتائج، وهو مرفق كـ Exhibit 99.1.

تم تقديم الكشف وفقاً لـ Item 2.02 وهو مخصص باعتباره “furnished”، بمعنى أنه ليس مستنداً كأنه مُقدم بموجب القسم 18 من قانون التبادل. يتم تداول أسهم Balchem العادية في ناسداك بالرمز BCPC.

Balchem Corporation 就截至2025年9月30日的季度业绩发表了对其业务的更新。公司发布了结果的新闻稿,作为Exhibit 99.1附件。

披露是在Item 2.02项下提供,并被标注为“furnished”,这意味着它不被视为根据美国证券交易法第18条提交。Balchem的普通股在纳斯达克交易,代码为BCPC

Positive
  • None.
Negative
  • None.

Balchem Corporation ha fornito un aggiornamento sull’andamento aziendale riportando gli utili del trimestre conclusosi il 30 settembre 2025. L’azienda ha emesso un comunicato stampa con i risultati, allegato come Exhibit 99.1.

La divulgazione è stata fornita ai sensi della Item 2.02 ed è designata come “furnished”, il che significa che non è considerata depositata ai sensi della Sezione 18 del Securities Exchange Act. Le azioni ordinarie di Balchem sono negoziate sul Nasdaq con simbolo BCPC.

Balchem Corporation presentó una actualización de su negocio al reportar las ganancias del trimestre terminado el 30 de septiembre de 2025. La compañía emitió un comunicado de prensa con los resultados, que se adjunta como Exhibit 99.1.

La divulgación se proporcionó bajo el Item 2.02 y se designa como “furnished”, lo que significa que no se considera presentada conforme a la Sección 18 de la Exchange Act. Las acciones comunes de Balchem cotizan en Nasdaq bajo el símbolo BCPC.

Balchem Corporation은 2025년 9월 30일 종료된 분기의 수익을 보고함으로써 자사 사업에 대한 업데이트를 제공합니다. 회사는 결과를 담은 보도자료를 발표했고, 이는 Exhibit 99.1로 첨부되어 있습니다.

공시는 Item 2.02에 따라 제공되었으며 "furnished"로 지정되어, Exchange Act 제18조에 따라 제출로 간주되지 않음을 의미합니다. Balchem의 보통주는 나스닥에서 심볼 BCPC로 거래됩니다.

Balchem Corporation a fourni une mise à jour de ses activités en déclarant les résultats du trimestre terminé le 30 septembre 2025. La société a publié un communiqué de presse avec les résultats, qui est joint en tant que Exhibit 99.1.

La divulgation a été fournie en vertu de Item 2.02 et est désignée comme « furnished », ce qui signifie qu’elle n’est pas réputée déposée en vertu de la Section 18 du Exchange Act. Les actions ordinaires de Balchem se négocient au Nasdaq sous le symbole BCPC.

Balchem Corporation hat ein Update zu seinem Geschäft vorgelegt, indem es die Ergebnisse für das Quartal zum 30. September 2025 gemeldet hat. Das Unternehmen veröffentlichte eine Pressemitteilung mit den Ergebnissen, die als Exhibit 99.1 beigefügt ist.

Die Offenlegung wurde gemäß Item 2.02 bereitgestellt und ist als „furnished“ gekennzeichnet, was bedeutet, dass sie gemäß Section 18 des Exchange Act nicht als eingereicht gilt. Balchems Stammaktien werden an der Nasdaq unter dem Symbol BCPC gehandelt.

false000000932600000093262025-10-212025-10-21

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (date of earliest event reported): October 21, 2025

Balchem Corporation
(Exact name of registrant as specified in its charter)
Maryland1-1364813-2578432
(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)

5 Paragon Drive, Montvale, NJ 07645
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (845) 326-5600

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbolName of each exchange on which registered
Common Stock, par value $.06-2/3 per shareBCPCThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company    
    
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.





Item 2.02     Results of Operations and Financial Condition

On October 21, 2025, Balchem Corporation reported earnings for the quarter ended September 30, 2025, and certain other information. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1.

The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01Financial Statements and Exhibits
(d)Exhibits
Exhibit No.Description
99.1
Press Release of Balchem Corporation, dated October 21, 2025, reporting its financial results for the third quarter of 2025 and certain other information
104Cover Page Interactive Data File (embedded within the Inline XBRL document)




SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 BALCHEM CORPORATION
  
 By:/s/ Hatsuki Miyata 
 Hatsuki Miyata
 Executive Vice President, Chief Legal Officer and Secretary
Date: October 21, 2025

FAQ

What did Balchem (BCPC) announce in this 8-K?

Balchem reported earnings for the quarter ended September 30, 2025 and furnished a press release as Exhibit 99.1.

Which period does the update cover for BCPC?

It covers the company’s financial results for the third quarter ended September 30, 2025.

Is the information in this 8-K considered filed or furnished?

The information is furnished under Item 2.02 and is not deemed filed under Section 18 of the Exchange Act.

Where can I find the detailed results for BCPC?

The detailed results are in the press release attached as Exhibit 99.1.

What is Balchem’s trading symbol and exchange?

Balchem’s common stock trades on The Nasdaq Stock Market LLC under the symbol BCPC.

What other exhibit accompanies the filing?

The filing includes the Cover Page Interactive Data File as Exhibit 104.
Balchem Corp

NASDAQ:BCPC

BCPC Rankings

BCPC Latest News

BCPC Latest SEC Filings

BCPC Stock Data

5.09B
32.20M
0.37%
90.95%
1.44%
Specialty Chemicals
Chemicals & Allied Products
Link
United States
MONTVALE